Hvad er CVR-nummeret på BIOSYNTIA ApS?

BIOSYNTIA ApS er registreret hos CVR / Virk under CVR 34892970.

Hvad er omsætningen for BIOSYNTIA ApS?

BIOSYNTIA ApS rapporterede en omsætning på DKK -14,1M i 2024.

BIOSYNTIA ApS beskæftiger 13 personer pr. seneste årsrapport.

Martin Plambech er administrerende direktør i BIOSYNTIA ApS, i rollen siden 2017.

Henrik Dalbøge er bestyrelsesformand i BIOSYNTIA ApS, i rollen siden 2014.

BIOSYNTIA ApSs registrerede adresse er Fruebjergvej 3.

APSActiveReklamebeskyttelse

CVR 34892970Fruebjergvej 3, 2100 København ØResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2012 · 13 years old13 employeeshttps://www.biosyntia.com

Aktivt ansatte i selskabet

Name	Role	Member since
Current (1)
MP Martin Plambech Chief Executive Officer	Chief Executive Officer	2017
Former (2)
HJ Hans Jasper Genee Chief Executive Officer	Chief Executive Officer	2014 – 2015
MO Morten Otto Alexander Sommer Chief Executive Officer	Chief Executive Officer	2015 – 2017

Ikke-udøvende tilsyn

Name	Role	Member since
Current (5)
TG Thomas Grotkjær Board of Directors	Board of Directors	2019
SS Sara Sande Board of Directors	Board of Directors	2022
HD Henrik Dalbøge Chairman	Chairman	2014
MJ Michael Jean Nettersheim Board of Directors	Board of Directors	2022
JB Joško Bobanović Board of Directors	Board of Directors	2018
Former (2)
SK Søren Knud Carlsen Board of Directors	Board of Directors	2015 – 2024
SM Søren Møller Board of Directors	Board of Directors	2015 – 2019

Pr. seneste årsrapport

Shareholder	Type	Ownership	Votes	Since
Novo Holdings A/S	Company	33.33–49.99%	33.33–49.99%	2022
Sofinnova Industrial Biotech I	Individual	25–33.32%	25–33.32%	2022
Danmarks Eksport- og Investeringsfond	Company	10–14.99%	10–14.99%	2023
ECBF I SCSp	Individual	10–14.99%	10–14.99%	2022
Praesidium S.C.A. SICAV-RAIF	Individual	5–9.99%	5–9.99%	2022
VÆKSTFONDEN	Company	10–14.99%	10–14.99%	2022

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.